Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP721255.RAFSBY8xwxJzPpkbYGaCaySIl2RU4hwCgYBkik43-NFY4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP721255.RAFSBY8xwxJzPpkbYGaCaySIl2RU4hwCgYBkik43-NFY4130_assertion type Assertion NP721255.RAFSBY8xwxJzPpkbYGaCaySIl2RU4hwCgYBkik43-NFY4130_head.
- NP721255.RAFSBY8xwxJzPpkbYGaCaySIl2RU4hwCgYBkik43-NFY4130_assertion description "[We evaluated the possible relation between plasma endothelin-1 (ET-1) levels and metabolic control, risk factors, treatment modalities, and diabetic microangiopathy, including nephropathy, neuropathy, and retinopathy in patients with Type 2 diabetes and healthy control group.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP721255.RAFSBY8xwxJzPpkbYGaCaySIl2RU4hwCgYBkik43-NFY4130_provenance.
- NP721255.RAFSBY8xwxJzPpkbYGaCaySIl2RU4hwCgYBkik43-NFY4130_assertion evidence source_evidence_literature NP721255.RAFSBY8xwxJzPpkbYGaCaySIl2RU4hwCgYBkik43-NFY4130_provenance.
- NP721255.RAFSBY8xwxJzPpkbYGaCaySIl2RU4hwCgYBkik43-NFY4130_assertion SIO_000772 11358684 NP721255.RAFSBY8xwxJzPpkbYGaCaySIl2RU4hwCgYBkik43-NFY4130_provenance.
- NP721255.RAFSBY8xwxJzPpkbYGaCaySIl2RU4hwCgYBkik43-NFY4130_assertion wasDerivedFrom befree-20140225 NP721255.RAFSBY8xwxJzPpkbYGaCaySIl2RU4hwCgYBkik43-NFY4130_provenance.
- NP721255.RAFSBY8xwxJzPpkbYGaCaySIl2RU4hwCgYBkik43-NFY4130_assertion wasGeneratedBy ECO_0000203 NP721255.RAFSBY8xwxJzPpkbYGaCaySIl2RU4hwCgYBkik43-NFY4130_provenance.